Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Overhaul of UK medicines legislation gets under way

This article was originally published in SRA

Executive Summary

The UK’s Medicines and Healthcare products Regulatory Agency has begun a three-year project to consolidate and review the national medicines legislation1. The Medicines Act 1968 has been expanded and changed so many times over the past 40 years that it is now a “very complex and fragmented set of legal provisions which are unwieldy to use and complicated to explain or understand”, says the agency. Some of the provisions may no longer be fit for purpose and may contradict current European Union-driven regulation, it adds.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS114190

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel